HUP0203741A2 - Eljárás oszteoporózis kezelésére - Google Patents

Eljárás oszteoporózis kezelésére

Info

Publication number
HUP0203741A2
HUP0203741A2 HU0203741A HUP0203741A HUP0203741A2 HU P0203741 A2 HUP0203741 A2 HU P0203741A2 HU 0203741 A HU0203741 A HU 0203741A HU P0203741 A HUP0203741 A HU P0203741A HU P0203741 A2 HUP0203741 A2 HU P0203741A2
Authority
HU
Hungary
Prior art keywords
treatment
osteoporosis
initial phase
estrogen compound
dose
Prior art date
Application number
HU0203741A
Other languages
English (en)
Inventor
Ulla Timonen
Raija Vaheri
Original Assignee
Orion Corp.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corp. filed Critical Orion Corp.
Publication of HUP0203741A2 publication Critical patent/HUP0203741A2/hu
Publication of HUP0203741A3 publication Critical patent/HUP0203741A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Abstract

A találmány tárgya csontritkulás kezelésére és megelőzésére szolgálóeljárás, amelyre jellemző, hogy a kezelés kezdeti szakaszában kisdózisban adunk ösztrogénvegyületet, majd a kezdeti szakasz után azösztrogénvegyület dózisát növelik. Ó
HU0203741A 1999-10-15 2000-10-13 Treatment of osteoporosis HUP0203741A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15950199P 1999-10-15 1999-10-15
PCT/FI2000/000890 WO2001026640A2 (en) 1999-10-15 2000-10-13 Treatment of osteoporosis

Publications (2)

Publication Number Publication Date
HUP0203741A2 true HUP0203741A2 (hu) 2003-02-28
HUP0203741A3 HUP0203741A3 (en) 2004-09-28

Family

ID=22572821

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0203741A HUP0203741A3 (en) 1999-10-15 2000-10-13 Treatment of osteoporosis

Country Status (13)

Country Link
EP (1) EP1223940B1 (hu)
JP (1) JP2003511409A (hu)
KR (1) KR20020048952A (hu)
AR (1) AR034100A1 (hu)
AT (1) ATE349215T1 (hu)
AU (1) AU778482B2 (hu)
CA (1) CA2388237C (hu)
CZ (1) CZ20021278A3 (hu)
DE (1) DE60032621T2 (hu)
HU (1) HUP0203741A3 (hu)
MX (1) MXPA02003770A (hu)
PL (1) PL354539A1 (hu)
WO (1) WO2001026640A2 (hu)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10125391B4 (de) * 2001-05-23 2005-01-27 Siemens Ag Vorrichtung zum Bestücken von Substraten mit elektrischen Bauelementen
JP2005504032A (ja) 2001-07-31 2005-02-10 ファイザー・プロダクツ・インク エストロゲン・アゴニスト／アンタゴニスト、エストロゲン及びプロゲスチンの組み合わせを含む医薬組成物、キット及び方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE92324T1 (de) * 1989-04-18 1993-08-15 Henning Berlin Gmbh Orale zubereitungsform des oestradiolvalerats.
DE59004243D1 (de) * 1990-06-14 1994-02-24 Henning Berlin Gmbh Flüssig befüllte Steckkapselpräparate.
DE4405591C1 (de) * 1994-02-22 1995-07-20 Hesch Rolf Dieter Prof Dr Med Mittel zur postmenopausalen Hormonsubstitution

Also Published As

Publication number Publication date
AR034100A1 (es) 2004-02-04
JP2003511409A (ja) 2003-03-25
WO2001026640A3 (en) 2001-10-18
DE60032621T2 (de) 2007-10-04
EP1223940A2 (en) 2002-07-24
HUP0203741A3 (en) 2004-09-28
KR20020048952A (ko) 2002-06-24
EP1223940B1 (en) 2006-12-27
DE60032621D1 (de) 2007-02-08
MXPA02003770A (es) 2002-12-13
PL354539A1 (en) 2004-01-26
WO2001026640A2 (en) 2001-04-19
AU7926300A (en) 2001-04-23
CA2388237C (en) 2010-06-01
CA2388237A1 (en) 2001-04-19
ATE349215T1 (de) 2007-01-15
CZ20021278A3 (cs) 2003-06-18
AU778482B2 (en) 2004-12-09

Similar Documents

Publication Publication Date Title
NZ514574A (en) Novel method of treatment
ATE339406T1 (de) Chinazoline verbindungen als heilmittel
CY1108725T1 (el) Συνδυασμος ανταγωνιστου-nmda και αναστολεων ακετυλοχολινεστερασης δια την θεραπειαν της νοσου alzheimer
HK1044528A1 (en) Monoamine reuptake inhibitors for treatment of cnsdisorders.
EA200702212A1 (ru) Способ лечения или профилактики разрушения кости или остеопороза
GB0002336D0 (en) Medicaments
MY141528A (en) Anilinopyrazole derivatives useful for the treatment of diabetes
MY134167A (en) Biphenylcarboxamides useful as lipid lowering agents
WO2004043456A8 (en) Cholesterol absorption inhibitors for the treatment of demyelination
TR199901104T2 (xx) Farmas�tik bile�ikler.
NO20040598L (no) 5-CNAC som oralt avleveringsmiddel for paratyreoidhormonfragmenter.
MXPA02012249A (es) Peptidos, composiciones y metodos para el tratamiento de burkholderia cepacia.
HUP0102380A2 (hu) Terápiás készítmény hiperkalcémiás krízis kezelésére
NO20002371L (no) 2-Arylbenzo[b]tiofener til behandling av østrogen- deprivasjonssyndrom
WO2004073615A3 (en) Deazaflavin compounds and methods of use thereof
GB9907571D0 (en) Compounds
MY138479A (en) 7alpha-hydroxyacetyl and 7alpha-hydroperoxyacetyl-substituted steroid compounds
DK1237562T3 (da) Fremgangsmåde til fremstilling af mikania-ekstrakter, som indeholder mikanolid og dihydromikanolid, og anvendelse i behandlingen af prolifererende sygdomme
BR0309032A (pt) Método para tratar sintomas vasomotores, a menopausa, deficiências hormonais em um paciente, e para tratar um paciente que sofre de sintomas vasomotores
HUP0203741A2 (hu) Eljárás oszteoporózis kezelésére
WO2002020000A3 (en) Combined estrogen blockade of the breast with exemestane and raloxifene
NO20054034L (no) Fremgangsmate for behandling av hypotyroidisme.
MXPA05008347A (es) Composicion que comprende una combinacion de un inhibidor de aromatasa, una progestina y un estrogeno y su uso para el tratamiento de endometriosis.
MY128529A (en) Use of cilobradine or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
HK1065305A1 (en) Substituted 4-aminocyclohexanol derivatives